Thrombosis: A Laboratory Diagnosis of Cerebral Sinus Venosus Thrombosis (CSVT) with Cardiac Myxoma

Cynthia (Laboratory of Clinical Pathology and Blood Bank, Mahar Mardjono National Brain Center Hospital, East Jakarta, Indonesia & Resident of Clinical Pathology Consultant Study Program, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia)
Suzanna Immanuel (Department of Clinical Pathology, Faculty of Medicine University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia)

ENDLESS : International Journal of Future Studies
Vol. 6 No. 1 (2023): ENDLESS : International Journal of Future Studies

Cerebral sinus venous thrombosis (CSVT) is a venous thromboembolism (VTE) is very rare about 0.5%-3% of all types of stroke, often found in young patients, estimated incidence in adults 3-4‰ and children 7‰, ratio of girls to boys 3:1.3,4,5,6 The main causes of CSVT differ in developed and developing countries. In preantibiotics, the main cause of CSVT is a septic process. Currently, it is generally due to the process aseptic. According to Bushnell et al. conversion to bleeding is reported to occur in 30-35% patient. Autopsy findings show that 10% of the causes of death are from cerebrovascular disease CSVT.3,4,5 We report a case of CSVT in a 83-year-old female patient. The patient had a diagnosis of CSVT with cardiac myxoma delivered to the laboratory from emergency room installation on the 28th December 2017, 12.40 WIB for routine hematology examination, PT, APTT, D-dimer, glucose while, SGOT, SGPT, urea, creatinine, electrolytes, calcium and magnesium with clinical evidence of decreased consciousness, convulsions and weakness of the right extremity.